High-dose neoadjuvant chemoradiotherapy versus chemotherapy alone followed by surgery in potentially-resectable stage IIIA-N2 NSCLC. A multi-institutional retrospective study by the Oncologic Group for the Study of Lung Cancer (Spanish Radiation Oncology Society)

  1. Montemuiño, S.
  2. Dios, N.R.D.
  3. Martín, M.
  4. Taboada, B.
  5. Calvo-Crespo, P.
  6. Samper-Ots, M.P.
  7. López-Guerra, J.L.
  8. López-Mata, M.
  9. Jové-Teixidó, J.
  10. Díaz-Díaz, V.
  11. Ingunza-Barón, L.D.
  12. Murcia-Mejía, M.
  13. Chust, M.
  14. García-Cañibano, T.
  15. Couselo, M.L.
  16. Puertas, M.M.
  17. Cerro, E.D.
  18. Moradiellos, J.
  19. Amor, S.
  20. Varela, A.
  21. Thuissard, I.J.
  22. Sanz-Rosa, D.
  23. Couñago, F.
Revue:
Reports of Practical Oncology and Radiotherapy

ISSN: 1507-1367

Année de publication: 2020

Volumen: 25

Número: 3

Pages: 447-455

Type: Article

DOI: 10.1016/J.RPOR.2020.03.006 GOOGLE SCHOLAR